The Hindu Businessline

Strides Pharma arm SPIAG inks $12 million deal to acquire Sandoz generics portfolio in Africa

Strides Pharma Science Limited expects the transaction to be EPS-accretive, supported by profitable branded sales, synergy realisation, and improved operating leverage